Navigation Links
Bluestar Silicones Presents Elastomer Solutions At Medical Design And Manufacturing (MD&M) East Show

PHILADELPHIA, June 13, 2013 /PRNewswire/ -- Bluestar Silicones will showcase its new Silbione® silicone elastomer solutions, including low durometer liquid silicone rubber (LSR) and self-bleeding LSR, at the upcoming Medical Design & Manufacturing (MD&M) East Conference (Booth #3744), June 18-20.  

Bluestar Silicones' new 1 Shore A (ShA) hardness product, Silbione LSR 4301, uniquely combines strong physical properties and easy processing in a low-durometer material. This product rounds out the company's 5 and 10 ShA soft LSR range, delivering high tear strength and elongation for soft cushioning and vibration dampening applications.

The company also introduces its new Silbione LSR 4755, which creates a lubricious surface on the molded part after vulcanization.  This lubricious material is designed to minimize friction and prevent slit healing in application.  Built into the bulk LSR formulation, the self bleeding lubricity of Silbione LSR 4755 eliminates the need for a secondary coating process to reduce coefficient of friction, reducing costs and improving cycle time for the part manufacturer.

"Bluestar Silicones is excited to present these specialty silicone solutions to the market," according to Karen O'Keefe, market manager, North America.  "The high performance physicals of our low durometer LSRs are unmatched in the industry.  And, our self-bleeding material provides a solution to the inherent non-slip surface of LSRs, improving productivity in automated assembly and part performance in select applications."

These specialty LSR products are manufactured in a clean room environment at Bluestar Silicones' new 226,000-sq-ft facility in York, S.C., and incorporate the distinctive advantages of Bluestar Silicones' standard LSR product line, including easy processing, easy release, and high-performance physical properties.

Bluestar Silicones also offers antimicrobial capability for OEMs and processors, which can be incorporated into its standard silicone products, providing a tailored material solution to meet specific healthcare requirements.

In addition to Bluestar Silicones' full line of LSR, the company offers high consistency rubbers (HCR), room-temperature vulcanized silicones (RTVs), skin adhesive tacky gels, cushioning gels and permanent adhesives for the healthcare market.  For more information, call (866) 474-6342.

About Bluestar Silicones

With worldwide operations headquartered in Lyon, France, Bluestar Silicones is a $650 million worldwide silicones raw material manufacturer. The company is one of the world's leading fully integrated global silicones manufacturers with more than 60 years of silicone expertise. Bluestar Silicones has manufacturing operations throughout the world and combines upstream silicon metal operations and capacity with downstream silicone market and application development expertise. The company offers a comprehensive range of silicone technologies in support of diverse specialty markets including paper release, textile coatings, healthcare, moldmaking, automotive, aerospace, and personal care. For more information, call (866) 474-6342.

Press Contact: Karen O'Keefe

SOURCE Bluestar Silicones
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
2. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
3. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
4. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
5. NewLink Genetics Presents Results from Two Phase 1 Studies with Immunotherapy Agent, Indoximod, at the ASCO 2013 Annual Meeting
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
8. NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
9. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
10. BioElectronics Presents FDA Reclassification Panel
11. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Post Your Comments:
(Date:11/24/2015)... 24, 2015 F1000Workspace - a ... since it was launched just six months ago. --> ... authoring platform for scientists - since it was launched just ... been loaded on to F1000Workspace - a research ... it was launched just six months ago. ...
(Date:11/24/2015)... Nov. 24, 2015 iRhythm Technologies, Inc. , a ... today announced that it will participate in the 27th Annual Piper ... New York, NY . Kevin King , ... December 1, 2015 at 8:50am ET. --> ... . --> . --> iRhythm ...
(Date:11/24/2015)... uptake of recently approved and pipeline premium products for Type 1 Diabetes ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . Type ...
Breaking Medicine Technology:
(Date:11/24/2015)... Texas (PRWEB) , ... November 24, 2015 , ... Charitable ... all charitable donations are made in the last five weeks of the year totalling ... was created in 2012 to connect the nation’s charities with those individuals who want ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... national leaders when it comes to several aspects of orthopedic care. They have ... replacements, orthopedic surgeries and general orthopedic care. , Becker's Hospital Review selected ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic student Katie Benson received ... in Overland Park, Kansas. Benson, a fifth-trimester student in the university’s College of ... on October 16. , “Katie is very excited and greatly appreciative to receive ...
Breaking Medicine News(10 mins):